IP Library Granted Patent US 12,551,701
Granted Patent B2
US 12,551,701 · App. 17/287,419 · Granted Feb 17, 2026

Charge monitor

Inventors: Peter Single (Artarmon, AU); Dean Karantonis (Maroubra, AU)
Assignee: Saluda Medical Pty Limited
A61N1/36139A61N1/025A61N1/36125A61N1/36142A61N1/36157A61N1/0551A61N1/36071
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,701
App. No.
17/287,419
Granted
Feb 17, 2026
Kind
B2
Abstract

This disclosure relates to implantable neuro stimulation devices with a feedback loop to control an amount of energy delivered into a neural tissue based on a measured evoked neural response. Stimulation electrodes deliver stimulation energy to neural tissue and a stimulator comprises a microprocessor and program memory with program code, which causes the microprocessor to perform closed-loop control of the stimulation energy based on a feedback signal that is indicative of an evoked neural response. A charge monitor monitors the delivery of energy to the stimulation electrodes by determining an amount of charge delivered by the stimulation electrodes and connected to the stimulator to provide a status signal indicative of the charge delivered to the stimulator. The device adjusts the control of the stimulation energy in response to the status signal from the charge monitor indicating undesirable charge delivery to the stimulation electrodes.

Claims (44)

1 . An implantable neuro-stimulation device comprising:

multiple stimulation electrodes configured to apply stimulation energy to neural tissue over a stimulus cycle;

an implantable stimulator comprising a controller, the controller configured to perform closed-loop control of the stimulation energy by controlling application of the stimulation energy to the neural tissue, the implantable stimulator further comprising

a charge monitor, the charge monitor comprising circuitry configured to determine an amount of charge delivered by the controller to the stimulation electrodes by the implantable stimulator, for each stimulus cycle of the stimulation energy during application of the stimulation energy to the neural tissue and prior to a subsequent stimulus cycle of the stimulation energy; the charge monitor circuitry being further configured to provide an error signal during the stimulus cycle when the amount of charge determined to be delivered to the stimulation electrodes exceeds a safe charge limit before the end of the stimulus cycle,

wherein

the controller is configured to perform the closed-loop control of the stimulation energy based on a feedback signal indicative of a neural response evoked by the applied stimulation energy; and

the controller is further configured to adjust the closed-loop control of the stimulation energy in response to the error signal, wherein the adjusting of the closed-loop control comprises stopping stimulation during the stimulus cycle or disabling closed loop control.

2 . The device of claim 1 , wherein

the implantable stimulator comprises a current source and the controller is configured to provide a current source activation signal to the current source to activate and de-activate the current source to thereby control the amount of charge delivered to the stimulation electrodes; and

the charge monitor is connected to the current source activation signal to monitor the delivery of energy to the stimulation electrodes by monitoring the current source activation signal.

3 . The device of claim 1 , wherein the implantable stimulator comprises a current source formed of a first and second transistor connected to each other by respective gate electrodes and the charge monitor is connected to the gate electrodes.

4 . The device of claim 3 , wherein the charge monitor comprises a third transistor with a gate electrode coupled to the gate electrodes of the first and second transistors, the third transistor providing through a source and drain electrode a current source activation signal.

5 . The device of claim 1 , wherein the charge monitor is configured to determine an integral of delivered current over a time period when stimulation is activated by the implantable stimulator.

6 . The device of claim 5 , wherein the charge monitor is further connected to a reference current signal indicative of an instant amplitude of a reference current and the integral over the time period is based on the reference current signal.

7 . The device of claim 1 , wherein the charge monitor is configured to monitor a stimulation activation signal from the implantable stimulator and the stimulation activation signal is a digital signal.

8 . The device of claim 1 , wherein the error signal is provided to the controller as an interrupt signal and the implantable stimulator is configured to adjust the control of the stimulation energy by way of an interrupt handling routine that adjusts the control of the stimulation energy.

9 . The device of claim 1 , wherein the implantable stimulator is configured to adjust the control of the stimulation energy by way of a hardware circuit that disables stimulation in response to the error signal.

10 . The device of claim 1 , wherein the implantable stimulator is configured to adjust the control of the stimulation energy by one or more of:

adjusting an amplifier gain of a feed-back loop;

adjust a stimulation level; and

enable/disable closed-loop therapy.

11 . The device of claim 1 , wherein the implantable stimulator is configured to create a data record on memory indicative of the error signal.

12 . The device of claim 1 , wherein the charge monitor is further configured to detect a charge imbalance error and in response, activate a charge imbalance status signal provided to the controller.

13 . The device of claim 12 wherein the charge imbalance status signal, an accumulated charge status signal and a charge waste status signal are combined with a status signal indicative of the amount of charge determined to be delivered to the stimulation electrodes into a single status signal.

14 . The device of claim 1 , wherein the charge monitor is further configured to detect an accumulated charge error and in response, activate an accumulated charge status signal provided to the controller, wherein the accumulated charge error is indicative of an accumulated charge estimate of one or more of the stimulation electrodes is non-zero during a shorting event.

15 . The device of claim 1 , wherein the charge monitor is further configured to detect a charge waste error and in response, activate a charge waste status signal provided to the controller, wherein the charge waste error is indicative of one or more of the stimulation electrodes being connected to both a sink and source at the same time.

16 . The implantable neurostimulator of claim 1 , wherein the controller is further configured to adjust the closed-loop control of the stimulation energy, by way of a hardware circuit that disables stimulation during application of the stimulus cycle, in response to the error signal.

17 . The implantable neurostimulator of claim 16 , wherein the hardware circuit comprises a switch in a power signal to the electrodes that is turned off by the error signal.

18 . A method for neuro-stimulation, the method comprising:

performing, using a controller of an implantable stimulator, closed-loop control of stimulation energy over a stimulation cycle;

delivering, using the implantable stimulator, the stimulation energy to multiple stimulation electrodes for application to neural tissue;

determining, by circuitry on the implantable stimulator, for each stimulus cycle of the stimulation energy during application of the stimulation energy to the neural tissue and prior to a subsequent stimulus cycle of the stimulation energy, an amount of charge delivered to the stimulation electrodes;

generating, by the implantable stimulator, a status signal indicative of the amount of charge determined to be delivered to the stimulation electrodes;

communicating, by the implantable stimulator, to the controller the status signal indicative of the amount of charge determined to be delivered to the stimulation electrodes;

performing, by the controller, the closed-loop control of the stimulation energy based on a feedback signal that is indicative of a neural response evoked by the delivered stimulation energy; and

adjusting, by the controller, the closed-loop control of the stimulation energy in response to the status signal comprising an error signal provided during the stimulus cycle, the error signal indicating that the determined amount of charge delivered to the stimulus electrodes exceeds a safe charge limit before the end of the stimulus cycle;

wherein the adjusting of the closed loop control comprises stopping stimulation during the stimulus cycle in which the error signal occurs, or disabling closed loop control.

19 . An implantable stimulator comprising:

a controller configured to control delivery of stimulation energy over a stimulus cycle to multiple stimulation electrodes, and

a charge monitor comprising circuitry of the implantable stimulator, the charge monitor configured to continuously determine during a stimulus cycle and prior to a subsequent stimulus cycle of the stimulation energy, an amount of charge delivered by the implantable stimulator to the stimulation electrodes,

wherein

the charge monitor circuitry is configured to set an error signal during the stimulus cycle, the error signal being indicative of the amount of charge determined to be delivered to the stimulation electrodes exceeding a safe charge limit before the end of the stimulus cycle;

the controller is configured to perform closed-loop control of the stimulation energy based on a feedback signal that is indicative of a neural response evoked by the delivered stimulation energy; and

the controller is further configured to disable the closed-loop control of the stimulation energy during the stimulus cycle in response to the error signal being set.

Assignments (2)
SECURITY INTEREST Recorded Mar 14, 2025
From: SALUDA MEDICAL PTY LTD
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070518/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2021
From: SINGLE, PETER; KARANTONIS, DEAN
To: SALUDA MEDICAL PTY LIMITED
Reel/Frame 056607/0754 →
Priority Claims (1)
AU 2018904016 · Oct 23, 2018 · national
Continuity (1)
Related Publication 20210387004A1 · Dec 16, 2021
References Cited (16)
US 7225016B1 · Koh · 2007 [cited by applicant]
US 7801600B1 · Carbunaru · 2010 [cited by examiner]
US 20050187590A1 · Boveja et al. · 2005 [cited by applicant]
US 20070162086A1 · DiLorenzo · 2007 [cited by examiner]
US 20110270359A1 · Colborn · 2011 [cited by examiner]
US 20130043829A1 · Gurlahosur · 2013 [cited by examiner]
US 20140243926A1 · Carcieri · 2014 [cited by examiner]
US 20170181669A1 · Lin et al. · 2017 [cited by applicant]
US 20180078761A1 · Bolea et al. · 2018 [cited by applicant]
US 20180085593A1 · Fayram · 2018 [cited by examiner]
WO WO2017142948A1 · 2017 [cited by examiner]
WO WO2019157559 · 2019 [cited by applicant]
WO WO2019157559A1 · 2019 [cited by examiner]
WO 2020082127A1 · 2020 [cited by applicant]
Australian Patent Office, International Search Report and Written Opinion of the International Searching Authority, International Application No. PCT/AU2019/051162, Feb. 17, 2020, 16 pages. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/AU2019/051162, Issued Apr. 27, 2021, 9 pgs. [cited by applicant]